Home

Diagnostikovat Hotel Spoušť acs med chem lett Darebák problém Pozvat

Readily Accessible High-Throughput Experimentation: A General Protocol for  the Preparation of ChemBeads and EnzyBeads | ACS Medicinal Chemistry Letters
Readily Accessible High-Throughput Experimentation: A General Protocol for the Preparation of ChemBeads and EnzyBeads | ACS Medicinal Chemistry Letters

ACS Med Chem Lett (@ACSMedChemLett) / Twitter
ACS Med Chem Lett (@ACSMedChemLett) / Twitter

Discovery and Optimization of Potent, Selective, and in Vivo Efficacious  2-Aryl Benzimidazole BCATm Inhibitors | ACS Medicinal Chemistry Letters
Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors | ACS Medicinal Chemistry Letters

Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester  Tenofovir Prodrugs | ACS Medicinal Chemistry Letters
Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs | ACS Medicinal Chemistry Letters

An Innovation 10 Years in the Making: The Stories in the Pages of ACS  Medicinal Chemistry Letters | ACS Medicinal Chemistry Letters
An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters | ACS Medicinal Chemistry Letters

Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable  and Brain Penetrant Mutant IDH1 Inhibitors | ACS Medicinal Chemistry Letters
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors | ACS Medicinal Chemistry Letters

Discovery and Development of Cyclic Peptide Inhibitors of CIB1 | ACS  Medicinal Chemistry Letters
Discovery and Development of Cyclic Peptide Inhibitors of CIB1 | ACS Medicinal Chemistry Letters

Featured Letter in ACS Medicinal Chemistry Letters – NITSCHE LAB
Featured Letter in ACS Medicinal Chemistry Letters – NITSCHE LAB

Identification of New Small-Molecule Inducers of Estrogen-related Receptor  α (ERRα) Degradation | ACS Medicinal Chemistry Letters
Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation | ACS Medicinal Chemistry Letters

Massively Parallel Optimization of the Linker Domain in Small Molecule  Dimers Targeting a Toxic r(CUG) Repeat Expansion | ACS Medicinal Chemistry  Letters
Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion | ACS Medicinal Chemistry Letters

Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2  Agonists | ACS Medicinal Chemistry Letters
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists | ACS Medicinal Chemistry Letters

Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with  Oral Bioavailability in Mice | ACS Medicinal Chemistry Letters
Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice | ACS Medicinal Chemistry Letters

Author Guidelines
Author Guidelines

ACS Medicinal Chemistry Letters: Volume 11, Issue 5
ACS Medicinal Chemistry Letters: Volume 11, Issue 5

Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry  Inhibition | ACS Medicinal Chemistry Letters
Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition | ACS Medicinal Chemistry Letters

Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors  in Cancer Therapy | ACS Medicinal Chemistry Letters
Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy | ACS Medicinal Chemistry Letters

Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for  Drug Discovery | ACS Medicinal Chemistry Letters
Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery | ACS Medicinal Chemistry Letters

Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In  Vitro and In Vivo Activity of an Oxadiazole Series | ACS Medicinal  Chemistry Letters
Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series | ACS Medicinal Chemistry Letters

Structural and Functional Characterization of Indane-Core CD4-Mimetic  Compounds Substituted with Heterocyclic Amines | ACS Medicinal Chemistry  Letters
Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines | ACS Medicinal Chemistry Letters

Development of Chimeric Molecules That Degrade the Estrogen Receptor Using  Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters
Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters

Identification and Structure-Guided Development of Pyrimidinone Based USP7  Inhibitors | ACS Medicinal Chemistry Letters
Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors | ACS Medicinal Chemistry Letters

Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as  Covalent Inhibitors of KRASG12C | ACS Medicinal Chemistry Letters
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C | ACS Medicinal Chemistry Letters

GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain  and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters

Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase  XII Inhibitors | ACS Medicinal Chemistry Letters
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors | ACS Medicinal Chemistry Letters